Evidence map›Paper›PMID 35440837›Full record

ArticleBulletin of the Korean Chemical Society2022

Synthesis and biological evaluation of 2-benzylaminoquinazolin-4(3

Jun Young Lee, Young Sup Shin, Sangeun Jeon, Se In Lee, Jung-Eun Cho, Subeen Myung, Min Seong Jang, Seungtaek Kim, Jong Hwan Song, Hyoung Rae Kim and 1 more

Abstract read
In one paragraph

Article in Bulletin of the Korean Chemical Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. The Genuine Carbene Conundrum.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Synthesis of Pore-Wall-Modified Stable COF/TiOAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  14. Recent Advances in Synthetic Routes to Azacycles.Molecules (Basel, Switzerland) · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Optimization of 2-Aminoquinazolin-4-(3Pharmaceuticals (Basel, Switzerland) · 2022
    Article
  19. Article
  20. Synthesis and biological evaluation of 2-benzylaminoquinazolin-4(3Bulletin of the Korean Chemical Society · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jun Young LeeCenter for Convergent Research of Emerging Virus Infection (CEVI) Korea Research Institute of Chemical Technology Yuseong-gu, Daejeon South Korea.
Young Sup ShinCenter for Convergent Research of Emerging Virus Infection (CEVI) Korea Research Institute of Chemical Technology Yuseong-gu, Daejeon South Korea.
Sangeun JeonZoonotic Virus Laboratory Institut Pasteur Korea Seongnam-si Gyeonggi-do South Korea.
Se In LeeCenter for Convergent Research of Emerging Virus Infection (CEVI) Korea Research Institute of Chemical Technology Yuseong-gu, Daejeon South Korea.
Jung-Eun ChoCenter for Convergent Research of Emerging Virus Infection (CEVI) Korea Research Institute of Chemical Technology Yuseong-gu, Daejeon South Korea.
Subeen MyungCenter for Convergent Research of Emerging Virus Infection (CEVI) Korea Research Institute of Chemical Technology Yuseong-gu, Daejeon South Korea.
Min Seong JangDepartment of Non-Clinical Studies Korea Institute of Toxicology Yuseong-gu, Daejeon South Korea.
Seungtaek KimZoonotic Virus Laboratory Institut Pasteur Korea Seongnam-si Gyeonggi-do South Korea.
Jong Hwan SongCenter for Convergent Research of Emerging Virus Infection (CEVI) Korea Research Institute of Chemical Technology Yuseong-gu, Daejeon South Korea.
Hyoung Rae KimCenter for Convergent Research of Emerging Virus Infection (CEVI) Korea Research Institute of Chemical Technology Yuseong-gu, Daejeon South Korea.
Chul Min ParkCenter for Convergent Research of Emerging Virus Infection (CEVI) Korea Research Institute of Chemical Technology Yuseong-gu, Daejeon South Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the continuing global crisis caused by coronavirus disease 2019 (COVID-19), there is still no effective treatment. Therefore, we designed and synthesized a novel series of 2-benzylaminoquinazolin-4(3

Indexed as

2‐benzylaminoquinazolin‐4(3H)‐onesantiviral activitycoronavirusesCOVID‐19

Identifiers

PMID35440837
PMCPMC9011860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.